The digital edition of all books may be viewed on our website before purchase. Excerpt from National Cancer Institute Annual Report
About the Publisher
Forgotten Books publishes hundreds of thousands of rare and classic books.
This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works. This text has been digitally restored from a historical edition. Some errors may persist, however we consider it worth publishing due to the work's historical value.The digital edition of all books may be viewed on our website before purchase.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Forgotten Books, London, Royaume-Uni
Paperback. Etat : New. Print on Demand. This book presents a comprehensive analysis of the Cancer Therapy Evaluation Program (CTEP), a vital component of the National Cancer Institute (NCI). The CTEP plays a crucial role in coordinating and monitoring clinical trials for cancer treatments, ensuring the safety and effectiveness of new therapies. The author provides a detailed account of the CTEP's history, structure, and functions, highlighting its impact on cancer research and patient care. Through the examination of various case studies, the book demonstrates the CTEP's rigorous approach to clinical trial design, data analysis, and regulatory oversight. The author also explores the challenges faced by the CTEP, including the need for efficient trial designs, effective communication with the medical community, and maintaining a balance between scientific rigor and patient safety. This book serves as a valuable resource for researchers, clinicians, and policymakers involved in cancer treatment development, offering insights into the complexities and importance of clinical trial evaluation in advancing the fight against cancer. This book is a reproduction of an important historical work, digitally reconstructed using state-of-the-art technology to preserve the original format. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in the book. print-on-demand item. N° de réf. du vendeur 9780243586332_0
Quantité disponible : Plus de 20 disponibles
Vendeur : Bulrushed Books, Moscow, ID, Etats-Unis
Etat : Like New. In unused condition, may show some slight shelf wear, but otherwise unread. This title was digitally scanned from a rare, out of print edition, and will have some visual artifacts from that process. N° de réf. du vendeur #265E-0294
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur LW-9780243586332
Quantité disponible : 15 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur LW-9780243586332
Quantité disponible : 15 disponible(s)